When did Glaxo Wellcome merger with SmithKline Beecham?
Michael Henderson
Published Mar 03, 2026
When did Glaxo Wellcome merger with SmithKline Beecham?
Jan. 17, 2000
Glaxo and SmithKline to merge – Jan. 17, 2000.
What did Glaxo Wellcome do?
These fifty years were pivotal in our history. During this period, we developed the first treatment for HIV, enhanced our consumer brands and developed new treatments for asthma. Company consolidation led to the formation of SmithKline Beecham and Glaxo Wellcome, which would ultimately merge to become GSK.
Who bought Beecham?
GlaxoSmithKline
Beecham Group
| Beecham’s Clock Tower built in 1877, the building still stands in St Helens, Merseyside today serving as the College Administrative centre | |
|---|---|
| Successor | SmithKline Beecham (now GlaxoSmithKline) |
| Headquarters | London, United Kingdom |
| Products | Phenethicillin, Methicillin |
| Parent | GlaxoSmithKline |
When was SmithKline founded?
December 2000
GlaxoSmithKline/Founded
Why did Glaxo Wellcome and SmithKline Beecham merger?
The key benefit of the merger for SmithKline Beecham is that the combined company’s increased pharmaceutical revenues will provide greater funds for pharmaceutical R&D. This will allow SmithKline Beecham to pursue research projects for which it did not previously have the necessary funding.
What happened to the Wellcome Foundation?
Towards the end of the 20th century, the Wellcome Trust decided to sell the company, which is now part of GlaxoSmithKline and no longer has any ownership or governance relationship with Wellcome. We do work with GlaxoSmithKline, as we work with many other healthcare companies, when it helps us to achieve our mission.
Who is SmithKline Beecham?
SmithKline Beecham Ltd. discovers, develops, manufactures, and markets pharmaceuticals, vaccines, over-the-counter medicines, and health-related consumer products. The Company provides healthcare services including clinical laboratory testing, disease management, and pharmaceutical benefit management.
Who is the CEO of GSK?
Emma Walmsley (Apr 2017–)
GlaxoSmithKline/CEO
Where was Glaxo started?
When was Glaxo Stevenage built?
The Medical Research Centre for the Glaxo Group was built by Laing-Morrison Knudsen in a joint venture between 1990-1995.
Does GSK have a Covid vaccine?
GSK commitment to tackling COVID-19 GSK’s response to COVID-19 has been one of the broadest in the industry, with two potential treatments in addition to our vaccine candidates in development. GSK is collaborating with several organisations on COVID-19 vaccines by providing access to our pandemic adjuvant.
